Market capitalization | €919.24m |
Enterprise Value | €996.21m |
PER (TTM) P/E ratio | 9.15 |
EV/FCF (TTM) EV/FCF | 5.88 |
EV/Sales (TTM) EV/Sales | 0.30 |
P/S ratio (TTM) P/S ratio | 0.27 |
P/B ratio (TTM) P/B ratio | 0.64 |
Dividend yield | 3.67% |
Last dividend (FY23) | €1.80 |
As a Free StocksGuide user, you can view scores for all 6,947 stocks worldwide.
5 Analysts have issued a Drägerwerk forecast:
5 Analysts have issued a Drägerwerk forecast:
Mar '24 |
+/-
%
|
||
Net Profit | 7.08 7.08 |
38%
38%
|
|
Depreciation and Amortization | 33 33 |
6%
6%
|
|
Stock Compensation | - - |
-
|
|
Operating Cash Flow | 34 34 |
893%
893%
|
|
Investments | 13 13 |
36%
36%
|
|
Dividend Paid | - - |
-
|
|
Free Cash Flow | 21 21 |
187%
187%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.